Native Antigen Fractionation Protein Microarrays for Biomarker Discovery

Methods in Molecular Biology

Volumn 723, Issue , 2011, Pages 129-148

  Caiazzo, Robert J ^a   O’Rourke, Dennis J ^a   Barder, Timothy J ^b   Nelson, Bryce P ^c   Liu, Brian C S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Eprogen   (United States)

^c Gentel Biosciences Inc ^*  (United States)

Author keywords

Autoantibodies; Autoantibody profiling; Cell lysate; Mass spectroscopy; PF 2D; Protein fractionation; Protein microarrays

Indexed keywords

ANTIGEN; AUTOANTIBODY; BIOLOGICAL MARKER; CELL EXTRACT; FLUORESCENT DYE; IMMUNOGLOBULIN G;

ARTICLE; BIOLOGY; CHEMISTRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; METHODOLOGY; PROTEIN MICROARRAY; REVERSED PHASE LIQUID CHROMATOGRAPHY; TUMOR CELL LINE;

ANTIGENS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CELL EXTRACTS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; COMPUTATIONAL BIOLOGY; FEMALE; FLUORESCENT DYES; HUMANS; IMMUNOGLOBULIN G; PROTEIN ARRAY ANALYSIS;

EID: 79958280471     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-043-0_9     Document Type: Chapter

References (11)

1. VanMeter A, Signore M, Pierobon M, Espina V, Liotta LA, Petricoin EF 3rd (2007) Reverse-phase protein microarrays: application to biomarker discovery and translational medicine. Expert Rev Mol Diagn 7:625–633
2. Charboneau L, Tory H, Chen T, Winters M, Petricoin EF 3rd, Liotta LA, Paweletz CP (2002) Utility of reverse phase protein arrays: applications to signaling pathways and human body arrays. Brief Funct Genomic Proteomic 1:305–315
3. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin IE, Liotta LA (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981–1989
4. Janzi M, Odling J, Pan-Hammarstrom Q, Sundberg M, Lundeberg J, Uhlen M, Hammarstrom L, Nilsson P (2005) Serum microarrays for large scale screening of protein levels. Mol Cell Proteomics 4:1942–1947
5. Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, Munson PJ, Petricoin E 3rd, Liotta LA, Weinstein JN (2003) Proteomic profiling of the NC1-60 cancer cell lines using new high density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 100:14229–14234
6. Taylor BS, Pal M, Yu J, Laxman B, Kalyana-Sundaram S, Zhao R, Menon A, Wei JT, Nesvizhskii AI, Ghosh D, Omenn GS, Lubman DM, Chinnaiyan AM, Sreekumar A (2008) Humoral response profiling reveals pathways to prostate cancer progression. Mol Cell Proteomics 7:600–611
7. Bouwman K, Qiu J, Zhou H, Schotanus M, Mangold LA, Vogt R, Erlandson E, Trenkle J, Partin AW, Misek D, Omenn GS, Haab BB, Hanash S (2003) Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity. Proteomics 3:2200–2207
8. Qiu J, Madoz-Gurpide J, Misek DE, Kuick R, Brenner DE, Michailidis G, Haab BB, Omenn GS, Hanash S (2004) Development of natural protein microarrays for the diagnosing cancer based on an antibody response to tumor antigens. J Proteome Res 3:261–267
9. Mattoon D, Michaud G, Merkel J, Schweitzer B (2005) Biomarker discovery using microarray technology platforms: antibody-antigen complex profiling. Expert Rev Proteomics 2:879–889
10. Sia SK, Linder V, Parviz BA, Siegel A, Whitesides GM (2004) An integrated approach to a portable and low-cost immuno-asay for resource-poor settings. Angew Chem Int Ed Engl 43:498–502
11. Huber M, Wei TF, Muller UR, Lefebvre PA, Marla SS, Bao YP (2004) Gold nanoparticle probe-based gene expression analysis with unamplified total human RNA. Nucleic Acids Res 32:e137